Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | VRTX | ||
| Company | Gilead Sciences Inc | Amgen Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 122.86 | 317.30 | 444.81 | ||
| High | 123.63 | 319.46 | 456.00 | ||
| Low | 119.53 | 315.19 | 444.81 | ||
| Latest | 120.40 | 317.74 | 452.04 | ||
| Change | -2.81 | +0.36 | +6.11 | ||
| % Change | -2.28% | +0.11% | +1.37% | ||
| Volume | 6,767,800 | 2,247,300 | 1,621,600 | ||
| 20-Day Average Volume | 7,054,955 | 2,860,580 | 1,390,000 | ||
| Previous Close | 123.21 | 317.38 | 445.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.22 | 334.04 | 437.64 | ||
| 20-Day Raw Stochastic | 16.37% | 15.75% | 73.94% | ||
| 20-Day Relative Strength | 47.25 | 47.77 | 59.32 | ||
| Weighted Alpha | +27.75 | +17.55 | +1.65 | ||
| Today's Opinion | 56% Buy | 72% Buy | 40% Buy | ||
| Previous Opinion | 72% Buy | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.68% since 12/05/25 | -3.68% since 12/05/25 | -0.76% since 12/05/25 | ||
| Low | 118.78 on 12/10/25 | 312.39 on 12/11/25 | 433.81 on 12/10/25 | ||
| High | 123.74 on 12/11/25 | 329.67 on 12/08/25 | 457.17 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | -2.43% since 11/12/25 | -5.51% since 11/12/25 | +4.11% since 11/12/25 | ||
| Low | 118.78 on 12/10/25 | 312.39 on 12/11/25 | 418.53 on 11/19/25 | ||
| High | 128.70 on 11/20/25 | 346.38 on 12/03/25 | 463.85 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +5.11% since 09/12/25 | +14.96% since 09/12/25 | +14.58% since 09/12/25 | ||
| Low | 108.46 on 10/02/25 | 269.77 on 09/26/25 | 374.17 on 09/24/25 | ||
| High | 128.70 on 11/20/25 | 346.38 on 12/03/25 | 463.85 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +7.45% since 06/12/25 | +6.88% since 06/12/25 | -1.74% since 06/12/25 | ||
| Low | 104.46 on 06/25/25 | 267.83 on 06/23/25 | 362.50 on 08/11/25 | ||
| High | 128.70 on 11/20/25 | 346.38 on 12/03/25 | 484.56 on 07/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 149,377,888 | 171,096,960 | 114,691,136 | ||
| Shares Outstanding, K | 1,240,680 | 538,481 | 253,719 | ||
| Annual Sales | 28,754,000,000 | 33,424,000,000 | 11,020,100,000 | ||
| Annual Net Income | 480,000,000 | 4,090,000,000 | -535,600,000 | ||
| Last Quarter Sales | 7,769,000,000 | 9,557,000,000 | 3,076,400,000 | ||
| Last Quarter Net Income | 3,052,000,000 | 3,216,000,000 | 1,082,900,000 | ||
| 60-Month Beta | 0.32 | 0.45 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.47 on 10/30/25 | 5.64 on 11/04/25 | 4.80 on 11/03/25 | ||
| Latest Earnings Date | 02/10/26 | 02/03/26 | 02/09/26 | ||
| Most Recent Dividend | 0.790 on 12/15/25 | 2.380 on 11/21/25 | N/A | ||
| Next Ex-Dividends Date | 12/15/25 | 02/13/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.04 | 14.51 | 29.13 | ||